Puberty Blockers Are Dangerous

While the impact of puberty blockers on the development of secondary sexual characteristics is widely acknowledged, their effects on cognitive functioning (IQ) are largely ignored.

Reality’s Last Stand is a reader-supported publication. Please consider becoming a paying subscriber or making a one-time or recurring donation to show your support.

About the Author

Dr. Pamela Williams (a pseudonym) is a 30-year qualified clinical psychologist and certified expert witness, specialising in child protection and family cases. She is also a certified Autism assessor. Her X (formerly Twitter) handle is @Psychgirl211

---

We are currently witnessing what may be the greatest medical scandal in history: the use of Puberty Blockers (PBs) in providing what is termed “Gender Affirming Care” (GAC).

Unlike other medical scandals, such as the Opiate crisis, this scandal uniquely targets children. Astonishingly, practitioners and regulatory bodies, who should be serving as gatekeepers and raising alarms, are fully complicit in this global, generational scandal.

The stated purpose of PBs in GAC, which it is being used off-label for, is to act as a “pause button” on puberty, supposedly giving children time to consider their gender identity while the development of secondary sexual characteristics is suspended by synthetic hormones such as Lupron, Zoladex, Trelstar, Supprelin, and Tiptodur. In the documentary “What Is A Woman?”, Dr. Michelle Forcier, a Professor of Pediatrics and Assistant Dean of Medicine at Brown University, infamously likened PBs to a music player’s pause function, suggesting that puberty can resume seamlessly once the blockers are stopped.

Puberty blockers, which are completely reversible and don’t have permanent effects, are wonderful because we can put that pause on puberty, just like if you were listening to music. You put the pause on, and we stop the blockers and puberty would go right back to where it was, the next note in the song, just delay that period of time.

However, PBs do not function in this way. Instead of being a temporary pause, they often cement gender dysphoria, which in most cases is merely a transient phase. Consequently, this leads about 98 percent of children who start PBs down a treatment path involving cross-sex hormones and, sometimes, surgeries.

A father, whose daughter had gone down that route, shared an analogy with me: Starting on PBs is like boarding a non-stop flight to Australia. Once airborne, there is no turning back until the destination is reached.